ORIGINAL ARTICLEPopulation pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial
Under an Elsevier user license
open archive
Keywords
dabigatran etexilate
nonmem
non‐valvular atrial fibrillation
population pharmacokinetics
RE‐LY
thrombin inhibitor
Cited by (0)
Copyright © 2011 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.